# Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC

> **NCT07052669** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 311 (estimated)

## Conditions studied

- Locally Advanced Non-Small Cell Lung Cancer

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy
- **RADIATION:** Conventionally Fractionated Radiation Therapy
- **DRUG:** Concurrent Chemotherapy
- **DRUG:** concurrent chemotherapy
- **DRUG:** Consolidative immunotherapy

## Key facts

- **NCT ID:** NCT07052669
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 311 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07052669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07052669, "Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07052669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*